Common Contracts
3 similar Supplemental Indenture contracts by Tellurian Inc. /De/, Biora Therapeutics, Inc.
BIORA THERAPEUTICS, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME and GLAS TRUST COMPANY LLC as Trustee and Collateral Agent INDENTURE Dated as of December 19, 2023 11.00% / 13.00 % Convertible Senior Secured Notes due 2028Supplemental Indenture • April 1st, 2024 • Biora Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of December 19, 2023, among Biora Therapeutics, Inc., a Delaware corporation, as issuer (the “Company”), the Guarantors party hereto from time to time (as defined herein), and GLAS Trust Company LLC, as trustee (in such capacity, the “Trustee”) and as collateral agent (in such capacity, the “Collateral Agent”).
TELLURIAN INC. and WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee and HB FUND LLC as Collateral Agent NINTH SUPPLEMENTAL INDENTURE Dated as of August 15, 2023 6.00% Senior Secured Convertible Notes due 2025Supplemental Indenture • August 16th, 2023 • Tellurian Inc. /De/ • Crude petroleum & natural gas • New York
This Supplemental Indenture (as defined below) is being executed and delivered pursuant to Sections 2.2 and 9.1(h) of the Base Indenture (as defined below) to establish the terms, and provide for the issuance, of a new series of Securities (as defined in the Base Indenture) constituting the Company’s 6.00% Senior Secured Convertible Notes due 2025 (the “Notes”).
TELLURIAN INC. and WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee and TECH OPPORTUNITIES LLC as Collateral Agent FIRST SUPPLEMENTAL INDENTURE Dated as of June 3, 2022 6.00% Senior Secured Convertible Notes due 2025Supplemental Indenture • June 3rd, 2022 • Tellurian Inc. /De/ • Crude petroleum & natural gas • New York
This Supplemental Indenture (as defined below) is being executed and delivered pursuant to Sections 2.2 and 9.1(h) of the Base Indenture (as defined below) to establish the terms, and provide for the issuance, of a new series of Securities (as defined in the Base Indenture) constituting the Company’s 6.00% Senior Secured Convertible Notes due 2025 (the “Notes”).
